Cited by 1,617HIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHIV Research and Treatment

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Open access

Kuller, Lewis H, Tracy, Russell, Belloso, Waldo, Wit, Stephane De, Drummond, Fraser, Lane, H. Clifford, Ledergerber, Bruno, Lundgren, Jens, Neuhaus, Jacqueline, Nixon, Daniel, Paton, Nicholas I, Neaton, James D, for the INSIGHT SMART Study Group·2008·PLoS Medicine

DOI 10.1371/journal.pmed.0050203PMC PMC2570418

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent, CD4-guided antiretroviral treatment (ART) (drug conservation [DC]) than continuous ART (viral suppression [VS]).We hypothesized that increased HIV-RNA levels following ART interruption induced activation of tissue factor pathways, thrombosis, and fibrinolysis. METHODS AND FINDINGS: Stored samples were used to measure six biomarkers: high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), amyloid A, amyloid P, D-dimer, and prothrombin fragment 1+2. Two studies were conducted: (1) a nested case-control study for studying biomarker associations with mortality, and (2) a study to compare DC and VS participants for biomarker changes. For (1), markers were determined at study entry and before death (latest level) for 85 deaths and for two controls (n = 170) matched on country, age, sex, and date of randomization. Odds ratios (ORs) were estimated with logistic regression. For each biomarker, each of the three upper quartiles was compared to the lowest quartile. For (2), the biomarkers were assessed for 249 DC and 250 VS participants at study entry and 1 mo following randomization. Higher levels of hsCRP, IL-6, and D-dimer at study entry were significantly associated with an increased risk of all-cause mortality. Unadjusted ORs (highest versus lowest quartile) were 2.0 (95% confidence interval [CI], 1.0-4.1; p = 0.05), 8.3 (95% CI, 3.3-20.8; p < 0.0001), and 12.4 (95% CI, 4.2-37.0; p < 0.0001), respectively. Associations were significant after adjustment, when the DC and VS groups were analyzed separately, and when latest levels were assessed. IL-6 and D-dimer increased at 1 mo by 30% and 16% in the DC group and by 0% and 5% in the VS group (p < 0.0001 for treatment difference for both biomarkers); increases in the DC group were related to HIV-RNA levels at 1 mo (p < 0.0001). In an expanded case-control analysis (four controls per case), the OR (DC/VS) for mortality was reduced from 1.8 (95% CI, 1.1-3.1; p = 0.02) to 1.5 (95% CI, 0.8-2.8) and 1.4 (95% CI, 0.8-2.5) after adjustment for latest levels of IL-6 and D-dimer, respectively. CONCLUSIONS: IL-6 and D-dimer were strongly related to all-cause mortality. Interrupting ART may further increase the risk of death by raising IL-6 and D-dimer levels. Therapies that reduce the inflammatory response to HIV and decrease IL-6 and D-dimer levels may warrant investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.0050203

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Exploratory Data Analysis
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,707
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Exploratory Data Analysis.
Birch, J. B., & Tukey, J. W. (1978) · Journal of the American Statistical Association · doi:10.2307/2286300 · Cited by 1,465
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women
Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B. L., Merz, C. N. B., Sopko, G. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115516.54550.b1 · Cited by 417
Problems due to Small Samples and Sparse Data in Conditional Logistic Regression Analysis
Greenland, S., Schwartzbaum, J., & Finkle, W. D. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010240 · Cited by 367

Flagged first, then by citations

Show all 42 references

1 of the 42 references couldn’t be matched to a known paper.

Research works printed but not linked: 38

De Larrangas, 2003, Blood Coagul Fibrinolysis, 14, 15
Torriani, 2008, J Am Coll Cardiol, 52, 569
Solages, 2006, Clin Infect Dis, 42, 1325
Lekakis, 2007, Euro Heart J (Suppl 1), 28, P2870
Wolf, 2002, J Infect Dis, 185, 456
Aziz, 1998, Clin Diagn Lab Immunol, 5, 755
Dolan, 2006, J Acquir Immune Defic Syndr, 39, 44
Lederman, 2000, AIDS, 14, 951
Lau, 2006, Arch Intern Med, 166, 64
Lifson, 2008, HIV Clin Trials, 9, 177
Sakkinen, 1999, Am J Epidemiol, 149, 261
Kuller, 1996, Am J Epidemiol, 144, 537
Johnson, 2004, Circulation, 109, 726
Harris, 1999, Am J Med, 106, 506
Ridker, 2000, Circulation, 101, 1767
Jenny, 2007, Arterioscler Thromb Vasc Biol, 27, 352
Danesh, 1999, Eur Heart J, 20, 954
Folsom, 2001, Thromb Haemost, 86, 366
Cushman, 1999, Arterioscler Thromb Vasc Biol, 19, 493
Danesh, 2001, Circulation, 103, 2323
Kooperberg, 2007, PLoS Clin Trials, 2
Cohen, 2003, Am J Med, 114, 180
Smith, 2005, Circulation, 112, 3080
Zakai, 2007, J Thromb Haemost, 5, 1128
Sasieni, 1992, Stat Med, 11, 617
Greenland, 2000, Am J Epidemiol, 151, 531
Peduzzi, 1996, J Clin Epidemiol, 49, 1373
Lowe, 2005, Semin Vasc Med, 5, 387
Lau, 2007, J Acquir Immune Defic Syndr, 44, 179
Shorr, 2002, CHEST, 121, 1262
Maldarelli, 2007, PLoS Pathog, 3, 484
Birdsall, 2002, AIDS, 16, 5
Brenchley, 2006, Nature Med, 12, 1365
Derhaschnig, 2004, Crit Care Med, 32, 1136
Boos, 2007, Am J Cardiol, 100, 986
Li, 2004, J Infect Dis, 189, 572
Decrion, 2005, Curr HIV Res, 3, 243
van Gorp, 1999, J Infect Dis, 180, 176

Sorted by citations

Items 501–600 of 1,000

Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance
Best, C. J., Struthers, H., Laciny, E., Royal, M., Reeds, D. N., & Yarasheski, K. E. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1531 · Cited by 40
HIV is an independent predictor of aortic stiffness
Rider, O. J., Asaad, M., Ntusi, N., Wainwright, E., Clutton, G., Hancock, G., Banerjee, R., Pitcher, A., Samaras, K., Clarke, K., et al. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-014-0057-1 · Cited by 40
HIV Status is An Independent Risk Factor for Reporting Lower Urinary Tract Symptoms
Breyer, B. N., Eeden, S. K. V. D., Horberg, M. A., Eisenberg, M. L., Deng, D. Y., Smith, J. F., & Shindel, A. W. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.12.043 · Cited by 40
Enhanced Effector Function of CD8+ T Cells From Healthy Controls and HIV-Infected Patients Occurs Through Thrombin Activation of Protease-Activated Receptor 1
Hurley, A., Smith, M., Karpova, T., Hasley, R. B., Belkina, N., Shaw, S. M., Balenga, N. A. B., Druey, K. M., Nickel, E., Packard, B. Z., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis730 · Cited by 40
Why START ? Reflections that led to the conduct of this large long‐term strategic HIV trial
The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group (2015) · HIV Medicine · doi:10.1111/hiv.12227 · Cited by 39
HIV and T follicular helper cells: a dangerous relationship
Vinuesa, C. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65175 · Cited by 39
Metabolic Consequences of HIV: Pathogenic Insights
Willig, A. L., & Overton, E. T. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0191-7 · Cited by 41
Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy
Ishizaka, A., Sato, H., Nakamura, H., Koga, M., Kikuchi, T., Hosoya, N., Koibuchi, T., Nomoto, A., Kawana‐Tachikawa, A., & Mizutani, T. (2016) · Journal of Virology · doi:10.1128/jvi.03158-15 · Cited by 39
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia
Guihot, A., Dentone, C., Assoumou, L., Parizot, C., Câlin, R., Seang, S., Soulié, C., Marcelin, A., Cálvez, V., Autran, B., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000815 · Cited by 39
Ageing with HIV
McGettrick, P., Barco, E. Á., & Mallon, P. W. G. (2018) · Healthcare · doi:10.3390/healthcare6010017 · Cited by 41
Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging
Belkina, A. C., Starchenko, A., Drake, K., Proctor, E. A., Pihl, R. M. F., Olson, A., Lauffenburger, D. A., Lin, N., & Snyder-Cappione, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02783 · Cited by 39
Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases
Butterfield, T. R., LANDAY, A. L., & Anzinger, J. J. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00484-4 · Cited by 39
The Role of Statins in the Setting of HIV Infection
Eckard, A. R., & McComsey, G. A. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0273-9 · Cited by 38
Lower Self-Reported Quality of Life in HIV-Infected Patients on cART and With Low Comorbidity Compared With Healthy Controls
Pedersen, K. K., Eiersted, M. R., Gaardbo, J. C., Pedersen, M., Gerstoft, J., Trøseid, M., & Nielsen, S. D. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000697 · Cited by 39
Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort
Stockdale, L. K., Nash, S., Nalwoga, A., Painter, H., Asiki, G., Fletcher, H. A., & Newton, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192086 · Cited by 41
Inflammation and Complications of HIV Disease
Dubé, M. P., & Sattler, F. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/652751 · Cited by 39
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
Kaufmann, G. R., Elzi, L., Weber, R. K., Furrer, H., Giulieri, S. G., Vernazza, P., Bernasconi, E., Hirschel, B. J., & Battegay, M. (2011) · AIDS · doi:10.1097/qad.0b013e3283430013 · Cited by 38
Noncirrhotic portal hypertension in HIV infection
Vispo, E., Morelló, J., Rodríguez‐Nóvoa, S., & Soriano, V. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283420f08 · Cited by 38
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
Kityo, C. M., Szubert, A. J., Siika, A. M., Heyderman, R. S., Bwakura‐Dangarembizi, M., Lugemwa, A., Mwaringa, S. M., Griffiths, A., Nkanya, I., Kabahenda, S., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002706 · Cited by 38
SIV Infection and the HIV Proteins Tat and Nef Induce Senescence in Adipose Tissue and Human Adipose Stem Cells, Resulting in Adipocyte Dysfunction
Gorwood, J., Ejlalmanesh, T., Bourgeois, C., Mantecon, M., Rose, C., Atlan, M., Desjardins, D., Grand, R. L., Fève, B., Lambotte, O., et al. (2020) · Cells · doi:10.3390/cells9040854 · Cited by 40
Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms
Bowman, E., Cameron, C., Richardson, B., Kulkarni, M., Gabriel, J., Cichon, M. J., Riedl, K. M., Mustafa, Y., Cartwright, M. J., Snyder, B., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008869 · Cited by 38
HIV Infection and the Risk of World Health Organization–Defined Sudden Cardiac Death
Freiberg, M. S., Duncan, M. S., Alcorn, C., Chang, C. H., Kundu, S., Mumpuni, A., Smith, E. K., Loch, S. F., Bedigian, A., Vittinghoff, E., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021268 · Cited by 38
Current state and limitations of daily oral therapy for treatment
Solomon, D. A., & Sax, P. E. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000165 · Cited by 38
Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the W omen, I ntegrase and F at A ccumulation T rial
Lake, J. E., McComsey, G., Hulgan, T., Wanke, C., Mangili, A., Walmsley, S. L., Stramotas, S., Tracy, R. P., & Currier, J. (2014) · HIV Medicine · doi:10.1111/hiv.12128 · Cited by 40
Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients
Peters, L., Mocroft, A., Soriano, V., Rockstroh, J. K., Rauch, A., Karlsson, A., Knysz, B., Pradier, C., Zilmer, K., Lundgren, J. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064283 · Cited by 38
When to Start Antiretroviral Therapy
Jain, V., & Deeks, S. G. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0044-6 · Cited by 38
Diabetes Mellitus, Cardiovascular Risk, and HIV Disease
Grinspoon, S. K. (2009) · Circulation · doi:10.1161/circulationaha.108.835710 · Cited by 38
Cardiovascular Risk Estimation Is Suboptimal in People With HIV
Triant, V. A., Lyass, A., Hurley, L. B., Borowsky, L. H., Ehrbar, R. Q., He, W. W., Cheng, D. T.-Y., Lo, J., Klein, D. B., Meigs, J. B., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.029228 · Cited by 37
Screening for chronic comorbid diseases in people with HIV : the need for a strategic approach
Peters, B., Post, F. A., Wierzbicki, A. S., Phillips, A. N., Power, L., Das, S., Johnson, M. A., Moyle, G. J., Hughes, L., Wilkins, E., et al. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2012.01055.x · Cited by 37
Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral Therapy
Zhang, S., van Sighem, A., Kesselring, A. M., Gras, L. A., Smit, C., Prins, J. M., Kauffmann, R. H., Richter, C., de Wolf, F., & Reiss, P. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318258c651 · Cited by 39
Elevated D-Dimer is Independently Associated with Endothelial Dysfunction: A Cross-Sectional Study in HIV-Infected Adults on Antiretroviral Therapy
Hileman, C. O., Longenecker, C. T., Carman, T. L., Milne, G. L., Labbato, D. E., Storer, N. J., White, C. A., & McComsey, G. A. (2012) · Antiviral Therapy · doi:10.3851/imp2297 · Cited by 37
Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients
León, A., Leal, L., Torres, B., Lucero, C., Inciarte, A., Arnedo, M., Plana, M., Vilà, J., Gatell, J. M., & García, F. (2015) · AIDS · doi:10.1097/qad.0000000000000596 · Cited by 37
Effect of Specific ART Drugs on Lipid Changes and the Need for Lipid Management in Children With HIV
Rhoads, M. P., Lanigan, J., Smith, C. J., & Lyall, E. G. H. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31821d33be · Cited by 37
Determinants of Mortality Among Postmenopausal Women in the Women's Health Initiative Who Report Rheumatoid Arthritis
Kuller, L. H., Mackey, R. H., Walitt, B. T., Deane, K. D., Holers, V. M., Robinson, W. H., Sokolove, J. B., Chang, Y., Liu, S., Parks, C. G., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38268 · Cited by 37
Loss of a Tyrosine-Dependent Trafficking Motif in the Simian Immunodeficiency Virus Envelope Cytoplasmic Tail Spares Mucosal CD4 Cells but Does Not Prevent Disease Progression
Breed, M. W., Jordan, A. P. O., Aye, P. P., Lichtveld, C. F., Midkiff, C. C., Schiro, F. R., Haggarty, B., Sugimoto, C., Alvarez, X. A., Utay, N. S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01928-12 · Cited by 36
One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
Psomas, C. K., Younas, M., Reynès, C., Cezar, R., Portalès, P., Tuaillon, É., Guigues, A., Merle, C., Atoui, N., Fernandez, C., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.008 · Cited by 37
Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1–infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275)
Nixon, D. E., Bosch, R. J., Chan, E. S., Funderburg, N., Hodder, S., Lake, J. E., Lederman, M. M., Klingman, K. L., Aberg, J. A., Bergstrom, K., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.09.017 · Cited by 37
Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy
Merlini, E., Tincati, C., Biasin, M., Saulle, I., Cazzaniga, F. A., Monforte, A. D., Cappione, A., Snyder-Cappione, J. E., Clerici, M., & Marchetti, G. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00614 · Cited by 37
Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection
Flentje, A., Kober, K. M., Carrico, A. W., Neilands, T. B., Flowers, E., Heck, N. C., & Aouizerat, B. E. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.016 · Cited by 38
Immune Activation, Proinflammatory Cytokines, and Conventional Risks for Cardiovascular Disease in HIV Patients: A Case-Control Study in Bahia, Brazil
Brites‐Alves, C., Luz, E., Netto, E. M., Ferreira, T., Diaz, R. S., Pedroso, C., Page, K. A., & Brites, C. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01469 · Cited by 37
HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood
Hocini, H., Bonnabau, H., Lacabaratz, C., Lefebvre, C., Tisserand, P., Foucat, E., Lelièvre, J., Lambotte, O., Sáez‐Cirión, A., Versmisse, P., et al. (2019) · Journal of Virology · doi:10.1128/jvi.01690-18 · Cited by 36
Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection
Bowman, E., & Funderburg, N. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00442-9 · Cited by 38
HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation
Olson, A., Coote, C., Snyder-Cappione, J. E., Lin, N., & Sagar, M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa657 · Cited by 35
HIV-1 Is Not a Major Driver of Increased Plasma IL-6 Levels in Chronic HIV-1 Disease
Shive, C. L., Biancotto, A., Funderburg, N., Pilch-Cooper, H. A., Valdez, H., Margolis, L. B., Sieg, S. F., McComsey, G. A., Rodriguez, B. A., & Lederman, M. M. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825ddbbf · Cited by 37
Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial
Baker, J. V., Hullsiek, K. H., Prosser, R. A., Duprez, D. A., Grimm, R. H., Tracy, R. P., Rhame, F. S., Henry, K., & Neaton, J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046894 · Cited by 37
Nutrition and inflammation serum biomarkers are associated with 12‐week mortality among malnourished adults initiating antiretroviral therapy in Zambia
Koethe, J. R., Blevins, M. L., Nyirenda, C. K., Kabagambe, E. K., Shepherd, B. E., Wester, C. W., Zulu, I., Chiasera, J. M., Mulenga, L., Mwango, A., et al. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-19 · Cited by 37
Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes: An Umbrella Review of Meta-analyses of Observational Studies
Grabovac, I., Veronese, N., Štefanac, S., Haider, S., Jackson, S. E., Koyanagi, A., Meilinger, M., Stubbs, B., Firth, J., Soysal, P., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz539 · Cited by 38
HIV-1 Tat protein inhibits the hematopoietic support function of human bone marrow mesenchymal stem cells
Yuan, Y., Zhou, C., Yang, Q., Ma, S., Wang, X., Guo, X., Ding, Y., Tang, J., Zeng, Y., & Li, D. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197756 · Cited by 36
Interleukin‐6 and d ‐dimer levels are associated with vascular dysfunction in patients with untreated HIV infection
Baker, J. V., Quick, H. H., Hullsiek, K. H., Tracy, R. P., Duprez, D. A., Henry, K., & Neaton, J. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2010.00835.x · Cited by 36
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010
Neaton, J. D., Neuhaus, J., & Emery, S. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed75d · Cited by 36
Antiretroviral therapy and preterm birth in HIV-infected women
Short, C.-E. S., & Taylor, G. P. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885837 · Cited by 36
Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers
Lipshultz, S. E., Williams, P. L., Zeldow, B., Wilkinson, J. D., RICH, K. C., Dyke, R. B. V., Seage, G. R., Dooley, L. B., Kaltman, J. R., Siberry, G. K., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000499 · Cited by 36
A Review of Management of Inflammation in the HIV Population
Slim, J., & Saling, C. F. (2016) · BioMed Research International · doi:10.1155/2016/3420638 · Cited by 35
A pilot study of brisk walking in sedentary combination antiretroviral treatment (cART)- treated patients: benefit on soluble and cell inflammatory markers
Bonato, M., Galli, L., Passeri, L., Longo, V., Pavei, G., Bossolasco, S., Bertocchi, C., Cernuschi, M., Balconi, G., Merati, G., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2095-9 · Cited by 36
Health Technology-Enabled Interventions for Adherence Support and Retention in Care Among US HIV-Infected Adolescents and Young Adults: An Integrative Review
Navarra, A.-M. D., Gwadz, M. V., Whittemore, R., Henry, S. B., Cleland, C. M., Burleson, W., Jacobs, S. K., & Melkus, G. D. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1867-6 · Cited by 37
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study
Castillo‐Mancilla, J., Phillips, A. N., Neaton, J. D., Neuhaus, J., Sharma, S., Baker, J. V., Collins, S., Mannheimer, S., Pett, S. L., Touzeau‐Römer, V., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25297 · Cited by 38
Impact of randomized antiretroviral therapy initiation on glucose metabolism
Erlandson, K. M., Kitch, D. W., Tierney, C., Sax, P. E., Daar, E. S., Melbourne, K. M., Ha, B., & McComsey, G. A. (2014) · AIDS · doi:10.1097/qad.0000000000000266 · Cited by 36
Workshop report: “Towards a Cure: HIV Reservoirs and Strategies to Control Them”
Jefferys, R. J. (2010) · Journal of the International AIDS Society · doi:10.1186/1758-2652-13-s3-i1 · Cited by 36
HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology
Hudson, J. A., Ferrand, R. A., Gitau, S. N., Mureithi, M., Maffia, P., Alam, S. R., & Shah, A. S. V. (2024) · Circulation Research · doi:10.1161/circresaha.124.323890 · Cited by 36
Aging of the human innate immune system in HIV infection
Zapata, H. J., & Shaw, A. C. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.06.007 · Cited by 35
Cystatin C in HIV-infected patients: promising but not yet ready for prime time
Gagneux‐Brunon, A., Mariat, C., & Delanaye, P. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs001 · Cited by 35
Clinical outcomes and antiretroviral therapy in ‘elite’ controllers: a review of the literature
Crowell, T. A., & Hatano, H. (2015) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30488-x · Cited by 35
Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals
Murray, D. D., Suzuki, K., Law, M. G., Trebicka, J., Neuhaus, J., Johnson, M. A., Vjecha, M. J., Kelleher, A. D., & Emery, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-11405-8 · Cited by 35
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial
Molina, J., Grund, B., Gordin, F. M., Williams, I. G., Schechter, M., Losso, M. H., Law, M. G., Ekong, E., Mwelase, N., Skoutelis, A. T., et al. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30003-1 · Cited by 36
Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study
Butler, J., Greene, S. J., Shah, S. H., Shah, S. J., Anstrom, K. J., Kim, R. J., Kalogeropoulos, A. P., Velazquez, E. J., Hernandez, A. F., Desvigne-Nickens, P. M., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.10.011 · Cited by 34
Frailty—A promising concept to evaluate disease vulnerability
Ribeiro, A. R., Howlett, S. E., & Fernandes, A. M. A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111217 · Cited by 37
Monocyte/Macrophage-Mediated Innate Immunity in HIV-1 Infection: From Early Response to Late Dysregulation and Links to Cardiovascular Diseases Onset
Teer, E., Joseph, D. E., Glashoff, R. H., & Essop, M. F. (2021) · Virologica Sinica · doi:10.1007/s12250-020-00332-0 · Cited by 37
Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV
Belury, M. A., Bowman, E., Gabriel, J., Snyder, B., Kulkarni, M., Palettas, M. S., Mo, X. M., Lake, J. E., Zidar, D. A., Sieg, S. F., et al. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i3.218 · Cited by 35
Primary HIV infection: clinical presentation, testing, and treatment.
Henn, A., Flateau, C., & Gallien, S. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0588-3 · Cited by 34
Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection
Passaes, C., Delagreverie, H. M., Avettand-Fènoël, V., David, A., Monceaux, V., Essat, A., Müller-Trutwin, M. C., Duffy, D., Castro, N. D., Wittkop, L., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00016-21 · Cited by 34
Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV
Hmiel, L., Zhang, S., Obare, L. M., Santana, M. A. D. O., Wanjalla, C. N., Titanji, B. K., Hileman, C. O., & Bagchi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137266 · Cited by 34
Host biomarkers distinguish dengue from leptospirosis in Colombia: a case–control study
Conroy, A. L., Gélvez, M., Hawkes, M., Rajwans, N., Liles, W. C., Villar, L. A., & Kain, K. C. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-35 · Cited by 33
Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy
Desvarieux, M., Boccara, F., Meynard, J., Bastard, J. P., Mallat, Z., Charbit, B., Demmer, R. T., Haddour, N., Fellahi, S., Tedgui, A., et al. (2013) · AIDS · doi:10.1097/qad.0b013e3283634819 · Cited by 34
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation
Bisio, F., Bozzano, F. M., Marras, F., Biagio, A. D., Moretta, L., & Maria, A. D. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.03.003 · Cited by 34
Non-AIDS-defining Cancers Among HIV-Infected Patients
Cutrell, J. B., & Bedimo, R. G. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0166-8 · Cited by 34
Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study
Crowell, T. A., Ganesan, A., Berry, S. A., Deiss, R., Agan, B. K., & Okulicz, J. F. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20524 · Cited by 34
High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid
Booiman, T., Wit, F. W. N. M., Maurer, I., Francesco, D. D., Sabin, C. A., Harskamp, A. M., Prins, M., Garagnani, P., Pirazzini, C., Franceschi, C., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx108 · Cited by 34
Human Immunodeficiency Virus 1 and Type I Interferons—Where Sex Makes a Difference
Ziegler, S. M., & Altfeld, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01224 · Cited by 34
Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis
Guerville, F., Vialemaringe, M., Cognet, C., Duffau, P., Lazaro, E., Cazanave, C., Bonnet, F., Leleux, O., Rossignol, R., Pinson, B., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003546 · Cited by 36
Obesity and Dyslipidemia in Behaviorally HIV‐Infected Young Women: Adolescent Trials Network Study 021
Mulligan, K. M., Harris, D. R., Monte, D., Stoszek, S., Emmanuel, P. J., Hardin, D. S., Kapogiannis, B. G., Worrell, C. J., Meyer, W. A., Sleasman, J. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/648728 · Cited by 34
Therapy for HIV
Peters, B. S., & Conway, K. (2011) · Advances in Dental Research · doi:10.1177/0022034511399082 · Cited by 33
Discrepant coagulation profile in HIV infection
Haugaard, A. K., Lund, T. T., Birch, C., Rönsholt, F. F., Trøseid, M., Ullum, H., Gerstoft, J., Johansson, P. I., Nielsen, S. D., & Ostrowski, S. R. (2013) · AIDS · doi:10.1097/01.aids.0000432462.21723.ed · Cited by 34
Inflammation and Fibrosis in HIV
Hsue, P. Y., & Tawakol, A. A. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.004427 · Cited by 34
Severity Biomarkers in Puumala Hantavirus Infection
Outinen, T. K., Mäkelä, S., Pörsti, I. H., Vaheri, A. I., & Mustonen, J. T. (2021) · Viruses · doi:10.3390/v14010045 · Cited by 33
The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice
Amand, M., Adams, P., Schober, R., Iserentant, G., Servais, J.-Y., Moutschen, M. P., & Seguin‐Devaux, C. (2023) · eLife · doi:10.7554/elife.83207 · Cited by 33
Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial
d’Ettorre, G., Baroncelli, S., Micci, L., Ceccarelli, G., Andreotti, M., Sharma, P., Fanello, G., Fiocca, F., Cavallari, E. N., Giustini, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109791 · Cited by 33
Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression
Hamlyn, E., Fidler, S. J., Stöhr, W., Cooper, D. A., Tambussi, G., Schechter, M., Miró, J. M., McClure, M. O., Weber, J. N., Babiker, A. G., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000155 · Cited by 34
Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy
da Silva, É. F. R., Charreau, I., Gourmel, B., Mourah, S., Kalidi, I., Guillon, B., Castro, N. D., Caron, F., Braun, J. M., Molina, J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit280 · Cited by 33
Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir
Højen, J. F., Rasmussen, T. A., Andersen, K. L. D., Winckelmann, A. A., Laursen, R. R., Gunst, J. D., Møller, H. J., Fujita, M., Østergaard, L. J., Søgaard, O. S., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00031 · Cited by 33
Effects of physical exercises on inflammatory biomarkers and cardiopulmonary function in patients living with HIV: a systematic review with meta-analysis
Ibeneme, S. C., Omeje, C. U., Myezwa, H., Ezeofor, S. N., Anieto, E. M., Irem, F. O., Nnamani, A. O., Ezenwankwo, E. F., & Ibeneme, G. C. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3960-0 · Cited by 38
Is low‐level HIV ‐1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
Elvstam, O., Medstrand, P., Jansson, M., Isberg, P.-E., Gisslén, M., & Björkman, P. (2019) · HIV Medicine · doi:10.1111/hiv.12756 · Cited by 33
Mutation of the ATP Cassette Binding Transporter A1 (ABCA1) C-Terminus Disrupts HIV-1 Nef Binding but Does Not Block the Nef Enhancement of ABCA1 Protein Degradation
Mujawar, Z., Tamehiro, N., Grant, A., Sviridov, D., Bukrinsky, M., & Fitzgerald, M. L. (2010) · Biochemistry · doi:10.1021/bi100466q · Cited by 33
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
Manner, I. W., Bækken, M., Oektedalen, O., & Os, I. (2012) · Blood Pressure · doi:10.3109/08037051.2012.680742 · Cited by 33
Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
Siika, A. M., McCabe, L., Bwakura‐Dangarembizi, M., Kityo, C. M., Mallewa, J., Berkley, J., Maitland, K., Griffiths, A., Baleeta, K., Mudzingwa, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1142 · Cited by 33
Omega‐3 fatty acid therapy reduces triglycerides and interleukin‐6 in hypertriglyeridemic HIV patients
Metkus, T., Timpone, J., Leaf, D., Goetz, M. B., Harris, W., & Brown, T. (2013) · HIV Medicine · doi:10.1111/hiv.12046 · Cited by 34
Elite control of HIV: is this the right model for a functional cure?
Cockerham, L. R., & Hatano, H. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.11.003 · Cited by 32
Using the Pathogenic and Nonpathogenic Nonhuman Primate Model for Studying Non-AIDS Comorbidities
Pandrea, I., LANDAY, A. L., Wilson, C. C., Stock, J. L., Tracy, R. P., & Apetrei, C. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0245-5 · Cited by 32
Tenofovir/Emtricitabine/Efavirenz Plus Rosuvastatin Decrease Serum Levels of Inflammatory Markers More Than Antiretroviral Drugs Alone in Antiretroviral Therapy-Naive HIV-Infected Patients
Calza, L., Vanino, E., Salvadori, C., Manfredi, R., Colangeli, V., Cascavilla, A., Bari, M. A. D., Motta, R., & Viale, P. (2014) · HIV Clinical Trials · doi:10.1310/hct1501-1 · Cited by 32
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
Sáez‐Cirión, A., Jacquelin, B., Barré‐Sinoussi, F., & Müller-Trutwin, M. C. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0436 · Cited by 32
Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems
Fuster, D., Cheng, D. M., Quinn, E. K., So‐Armah, K., Saitz, R., Freiberg, M. S., Samet, J. H., & Tsui, J. I. (2014) · AIDS · doi:10.1097/qad.0000000000000184 · Cited by 32

Authors: Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., Paton, N. I., Neaton, J. D., & for the INSIGHT SMART Study Group
Affiliations: University of Pittsburgh (US)
University of Vermont (US)
Hospital Italiano de Buenos Aires (AR)
UNSW Sydney (AU)
National Institutes of Health (US)
University Hospital Zurich (CH)
University of Copenhagen (DK)
University of Minnesota (US)
Virginia Commonwealth University (US)
Medical Research Council (GB)
Corresponding author: Neaton, James D
ORCID: Kuller, Lewis H
Tracy, Russell
Belloso, Waldo
Drummond, Fraser
Lane, H. Clifford
Ledergerber, Bruno
Lundgren, Jens
Paton, Nicholas I
Neaton, James D
Venue: PLoS Medicine
Publisher: Public Library of Science (PLoS)
Published: 2008-10-21
Volume: 5
Issue: 10
Pages: e203
ISSN: 1549-1277 (ISSN-L)
1549-1676
DOI: 10.1371/journal.pmed.0050203
PMC: PMC2570418
OpenAlex: W2153136696
Cited by: 1,617
References: 42
Citations by year: 2026: 40 · 2025: 42 · 2024: 57 · 2023: 56 · 2022: 70 · 2021: 77 · 2020: 98 · 2019: 82 · 2018: 105 · 2017: 86 · 2016: 120 · 2015: 129 · 2014: 146 · 2013: 142 · 2012: 118
FWCI: 53.14
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (unspecified)
Locations: PLoS Medicine (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by)
Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, cc-by)
National University of Singapore (submittedVersion)
VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, public-domain)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
Zurich Open Repository and Archive (University of Zurich)
Funders: Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Gilead Sciences
Wake Forest University
Johns Hopkins University
National Institutes of Health
National Institute of Allergy and Infectious Diseases (U01 AI46362, U01AI046362, U01AI042170)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: HIV infection, all-cause mortality, inflammatory markers, coagulation markers, C-reactive protein, interleukin-6, D-dimer, prothrombin fragment 1+2, amyloid A, antiretroviral therapy interruption, viral rebound, thrombosis, fibrinolysis, tissue factor
MeSH terms: Serum Amyloid P-Component, Serum Amyloid A Protein, Blood Coagulation, C-Reactive Protein, Cause of Death, Female, Fibrin Fibrinogen Degradation Products, Follow-Up Studies, Humans, Inflammation, Male, Multicenter Studies as Topic, Biomarkers, HIV Infections, Interleukin-6, Survival Rate, Logistic Models, Odds Ratio, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Anti-HIV Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks